Gilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million ...

Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...

There was some good news in the clinical sphere for Gilead Sciences (NASDAQ: GILD) on Thursday, and this drove its stock ...

Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $81.44 which represents a slight increase of $2.27 or 2.87% from the prior close of $79.17. The stock opened at $79.17 and ...

The latest trading day saw Gilead Sciences (GILD) settling at $83.08, representing a -0.1% change from its previous close.

But we should not assume that Gilead Sciences’ stock price will not be affected by a steep bear market. Most likely it will decline as well – but maybe the decline is less steep and maybe the ...

Leerink Partners analyst Daina Graybosch has maintained their neutral stance on GILD stock, giving a Hold rating on September 12. “Daina ...

Buying $100 In GILD: If an investor had bought $100 of GILD stock 20 years ago, it would be worth $902.07 today based on a ...

Mohit Bansal, an analyst from Wells Fargo, maintained the Hold rating on Gilead Sciences (GILD – Research Report). The associated price ...

Johanna Mercier, Chief Commercial Officer of Gilead Sciences Inc (NASDAQ:GILD), sold 29,357 shares of the company on 12, 2024 ...

Headlines,Gilead Sciences, (NASDAQ:GILD),saw a significant rise in its stock price, driven by promising results from a Phase ...